In The News Posted March 4, 2019 Share Posted March 4, 2019 TAIPEI, Taiwan, March 4, 2019 /PRNewswire/ -- Lorati Company Limited, a Taiwan-based biotechnology and pharmaceutical company, today announced that it has successfully developed nano-grade eye drops, which can effectively treat and reverse Stargardt disease. Lorati CEO, David Lo, said... View the full article Link to comment Share on other sites More sharing options...
Recommended Posts
Archived
This topic is now archived and is closed to further replies.